Mrv0541 09111222022D 14 13 0 0 1 0 999 V2000 1.7587 1.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0442 1.1106 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3298 1.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3847 1.1106 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.3847 0.2856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3298 -0.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3298 -0.9519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3847 -1.3644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0992 -0.9519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0992 -0.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3847 -2.1894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0442 -1.3644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0992 1.5231 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.9980 0.0000 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 6 7 1 0 0 0 0 7 8 2 0 0 0 0 8 9 1 0 0 0 0 9 10 2 0 0 0 0 5 10 1 0 0 0 0 8 11 1 0 0 0 0 7 12 1 0 0 0 0 4 13 1 1 0 0 0 M END > T3D4764 > t3db > Cl.CNC[C@H](O)C1=CC(O)=C(O)C=C1 > InChI=1S/C9H13NO3.ClH/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;/h2-4,9-13H,5H2,1H3;1H/t9-;/m0./s1 > ATADHKWKHYVBTJ-FVGYRXGTSA-N > C9H14ClNO3 > 219.665 > 219.066221026 > 4 > 18.82576853397501 > 1 > 4 > 0 > 0 > 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol hydrochloride > -0.42952928501713206 > 0 > 1 > 1 > 12.652804138341846 > 9.694259402931468 > 8.912171883219303 > 72.72 > 49.2303 > 3 > 1 > epinephrine hydrochloride > 0 > T3D4764 > Erythromycin > 114-07-8 > 3''-O-demethylerythromycin; Abomacetin; Akne-Mycin; E.E.S; E.E.S.; EM; Eritromicina; Ery; Ery-Ped; ERY-TAB; Eryc; Erygel; Erythra-Derm; Erythrocin Stearate; Erythromycin A; Erythromycin C; Erythromycin ethylsuccinate; Erythromycin glucoheptonate; Erythromycin lactobionate; Erythromycin oxime; Erythromycin Stearate; Erythromycine; Erythromycinum; Ilosone; ILOTYCIN; Staticin; T-stat > Organic Compound; Amine; Ether; Ester; Drug; Anti-Bacterial Agent; Protein Synthesis Inhibitor; Gastrointestinal Agent; Metabolite; Synthetic Compound; Macrolide $$$$